NDC 17856-0273-2 - Codeine-Guaifenesin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0273
- Requested NDC
- 17856-0273-2
- Package NDCs from labels
- 17856-0273-2, 17856-0273-1
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2024-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Codeine-Guaifenesin - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-05-08 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0273-1 | 2024-05-08 | C162847 | 48780-1 | 1030e365-660e-111a-e063-dadaa90a10e2 | Codeine-Guaifenesin |
| 17856-0273-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-660e-111a-e063-dadaa90a10e2 | Codeine-Guaifenesin |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0273-1 | Codeine-Guaifenesin | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-0273-2 | Codeine-Guaifenesin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0273 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 2 package rows | 20240509_e9705358-3522-46b3-a860-afb9141968b4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0273-1 | ML - Milliliter | 17856-0273 | a0910118-47e5-4f96-9a75-8529d572bf0c | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ChemDetox | BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), PHYTOLACCA DECANDRA, THYROIDINUM (SUIS), IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM | Dr. Donna Restivo DC | 2a17f80d-12c0-43a0-980b-9da648e9b76a | 2023-01-10 | Warnings | 506T60A25R |
| DAYTIME COLD AND FLU Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIFENESIN, PHENYLEPHRINE HCL | Walgreens | dbf5656b-9105-871b-e053-2995a90a4941 | 2023-01-03 | Warnings | M012 495W7451VQ |
| Mucus Relief Extended Release Maximum Strength | GUAIFENESIN | H E B | 6f075c29-8256-4cac-96c4-a772a53ad21d | 2022-12-09 | Warnings | 495W7451VQ |
| Guaifenesin and Dextromethorphan HBr | GUAIFENESIN AND DEXTROMETHORPHAN HBR | PUBLIX SUPER MARKETS, INC | 9870b7ee-2bfb-42f5-9762-77d2dd13434a | 2022-12-06 | Warnings | 495W7451VQ |
| Guaifenesin and Dextromethorphan Hydrobromide HBR | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | RITE-AID | 2343f031-d658-498a-b5d1-6dcdb26b3cf0 | 2022-12-06 | Warnings | 495W7451VQ |
| Guaifenesin and Dextromethorphan HBr | GUAIFENESIN AND DEXTROMETHORPHAN HBR | SUN PHARMACEUTICAL INDUSTRIES, INC. | 06328741-03e3-49cf-ae44-d4c2116e38a3 | 2022-12-06 | Warnings | 495W7451VQ |
| MAXIMUM STRENGTH Mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | CVS Pharmacy | 9a560b80-972c-4af5-8fe8-eaef0b0d83b3 | 2022-12-01 | Warnings | 495W7451VQ |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| GUAIFENESIN | GUAIFENESIN | CVS | 4efa8bf9-3394-47b4-b630-9476b15d2dfc | 2022-11-23 | Warnings | 495W7451VQ |
| Mucus Relief Extended Release | GUAIFENESIN | Care One (American Sales Company) | 96569c70-0936-4041-ab32-2b2262402f34 | 2022-11-21 | Warnings | 495W7451VQ |
| Mucus Relief Maximum Strength | GUAIFENESIN | Care One (American Sales Company) | c94e3943-20da-4bd4-b0ff-6aa60b03a1bf | 2022-11-21 | Warnings | 495W7451VQ |
| Mucus Relief | GUAIFENESIN | McKesson Corporation dba SKY Packaging | 69b61f05-8f0b-420f-b4ef-df933b70eebc | 2022-11-21 | Warnings | 495W7451VQ |
| DG health mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Dolgencorp, LLC | add72ca5-94cd-437f-b30f-6149c08b5f21 | 2022-11-14 | Warnings | 495W7451VQ |
| Mucus Relief | GUAIFENESIN | H E B | 562b6ab6-4795-4909-8008-e919173844c9 | 2022-11-07 | Warnings | 495W7451VQ |
| DAYTIME-NIGHTTIME SEVERE COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | KROGER | a2508699-08c0-4a22-e053-2a95a90a8a6d | 2022-11-02 | Warnings | M012 |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Care One (Retail Business Services, LLC.) | eb3ef974-4e79-4065-a8c9-9307092da6b3 | 2022-10-21 | Warnings | 495W7451VQ |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Care One (Retail Business Services, LLC.) | 93658f3c-1f57-41b5-acdc-ee7ee47656a3 | 2022-10-21 | Warnings | 495W7451VQ |
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | Cardinal Health (Leader) 70000 | 04af43e6-6276-42ec-a902-3de22bc9fdea | 2022-10-20 | Warnings | 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.